section name header

Pronunciation

eye-soe-proe-TER-e-nole

Classifications

Therapeutic Classification: antiarrhythmics, bronchodilators

Pharmacologic Classification: adrenergics

Indications

High Alert

Action

Therapeutic Effects:

Pharmacokinetics

Absorption: IV administration results in complete bioavailability.

Distribution: Unknown.

Metabolism/Excretion: Metabolism occurs in the lung, liver, and other tissues; 50% excreted unchanged by the kidneys.

Half-life: 2.5–5 min.

Time/Action Profile

(bronchodilation)

ROUTEONSETPEAKDURATION
IVimmediateunknown<1 hr

Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

CV: angina, hypertension, tachycardia, ARRHYTHMIAS.

Endo: hyperglycemia.

GI: nausea, vomiting, xerostomia.

Neuro: nervousness, restlessness, tremor, headache, insomnia.
Misc: pink/red discoloration of saliva.

Interactions

Drug-Drug:

Route/Dosage

see Calculator

Availability

(Generic available)

Assessment

Lab Test Considerations: Toxicity and Overdose:

Implementation

Patient/Family Teaching

Evaluation/Desired Outcomes

US Brand Names

Isuprel